Conditions: Chronic Schizophrenia
Keywords: Schizophrenia SM-13496 Latuda Lurasidone
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 240
Healthy volunteers: no

Brief summary:
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe as compared with quetiapine XR long term among schizophrenic outpatients with chronic schizophrenia.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Lurasidone HC1 intervention 2: Quetiapine XR
Intervention descriptions: intervention 1: Lurasidone 40-160 mg/day flexibly dosed. intervention 2: Quetiapine XR 200-800 mg/day flexibly dosed.

Protocol document: